LGND · Ligand Pharmaceuticals Inc · Fails to Deliver
$322.75
+5.42 (+1.71%)
At close · Oct 30
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$6.43B
Shares
20.00M
Volume · Oct 30
344.37K
Avg daily vol (3M)
241.18K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 156 | $310.36 | $48,416 |
| 2026-09-24 | 546 | $298.41 | $162,932 |
| 2026-09-21 | 94 | $283.49 | $26,648 |
| 2026-09-18 | 219 | $284.70 | $62,349 |
| 2026-09-16 | 54 | $276.98 | $14,957 |
| 2026-09-11 | 2,018 | $289.25 | $583,707 |
| 2026-09-03 | 5,586 | $286.92 | $1,602,735 |
| 2026-09-02 | 211 | $284.27 | $59,981 |
| 2026-09-01 | 10 | $284.10 | $2,841 |
| 2026-08-31 | 1,681 | $280.49 | $471,504 |
| 2026-08-28 | 182 | $284.52 | $51,783 |
| 2026-08-20 | 6 | $290.71 | $1,744 |
| 2026-08-14 | 6,144 | $288.82 | $1,774,510 |
| 2026-08-05 | 7 | $300.79 | $2,106 |
| 2026-08-04 | 11 | $292.04 | $3,212 |
| 2026-08-03 | 23 | $287.54 | $6,613 |
Showing 1–16 of 16 settlements
Key facts
CIK
886163
CUSIP
53220K504
13F (30d)
134 filings
125 filers
Visit website
Investor relations